Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by bfwon Dec 20, 2018 1:08pm

96 Views

Post# 29141443

RE:RE:RE:RE:RE:RE:Happy Holidays

XBI down 3.33%

TH down 2.20%

It's actually outperforming in an awful tape.

bfw

PinnacleX wrote: Well, there ya go happy holidays as this mistake keeps tanking, lower high confirmed and maybe it can just hit 6.50 and not lower. These lower high candles are down to a T, its like you can see it coming from a month away.

Bullboard Posts

Golden Minerals closes Yoquivo gold-silver project sale